| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT03188393 |
| P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
| P17 | country | United States of America | Q30 |
| P582 | end time | 2018-12-01 | |
| P2899 | minimum age | 18 | |
| P1132 | number of participants | 175 | |
| P6153 | research site | Vanderbilt University | Q29052 |
| Yale University | Q49112 | ||
| West Virginia University | Q115376 | ||
| University of Chicago | Q131252 | ||
| University of Toronto | Q180865 | ||
| University of North Carolina at Chapel Hill | Q192334 | ||
| University of Pittsburgh | Q235034 | ||
| Ohio State University | Q309331 | ||
| Northwestern University | Q309350 | ||
| Wake Forest University | Q392667 | ||
| University of Alabama | Q492318 | ||
| Rutgers University | Q499451 | ||
| Case Western Reserve University | Q1047060 | ||
| Yeshiva University | Q1048851 | ||
| Mayo Clinic | Q1130172 | ||
| Mount Sinai Hospital | Q1476505 | ||
| Rush University Medical Center | Q1535116 | ||
| Denver Health Medical Center | Q3023367 | ||
| Jewish General Hospital | Q3145341 | ||
| Allegheny General Hospital | Q4731305 | ||
| Greater Baltimore Medical Center | Q5600442 | ||
| Hennepin County Medical Center | Q5714832 | ||
| Loyola University Medical Center | Q6694611 | ||
| Atrium Health Navicent The Medical Center | Q6806287 | ||
| Memorial Medical Center | Q6815474 | ||
| Piedmont Hospital | Q7191520 | ||
| Roswell Park Comprehensive Cancer Center | Q7370121 | ||
| Swedish Medical Center | Q7654755 | ||
| University Health Truman Medical Center | Q7847720 | ||
| University of Oklahoma Health Sciences Center | Q7896014 | ||
| Washington University School of Medicine | Q7972509 | ||
| Sentara Norfolk General Hospital | Q13527986 | ||
| UNM Los Lunas | Q30258334 | ||
| Duke University Medical Center | Q30279912 | ||
| Aurora Sinai Medical Center | Q30280597 | ||
| Colorado Blood Cancer Institute | Q43896855 | ||
| Aurora BayCare Medical Center | Q50036553 | ||
| Freeman Health System | Q50039515 | ||
| P859 | sponsor | NRG Oncology | Q30270252 |
| P580 | start time | 2017-04-13 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | A Phase II Trial Assessing the Accuracy of Tumor Bed Biopsies in Predicting Pathologic Response in Patients With Clinical/Radiologic Complete Response After Neoadjuvant Chemotherapy in Order to Explore the Feasibility of Breast Conserving Treatment Without Surgery |
Search more.